By Sheri R. Colberg, PhD, FACSM
It's known that lack of exercise, poor eating habits, genetics, and lifestyle factors can all contribute to the onset of prediabetes and type 2 diabetes. I have spent many years touting the benefits of lifestyle change to prevent and manage these health conditions—and in some cases reverse them. Exercise is a particularly important lifestyle management tool because of its ability to lower inflammation (the underlying cause of insulin resistance) naturally.

In your experience, what have most studies about CGM demonstrated?

- HbA1c is lower in CGM users regardless of age or type of insulin delivery.
- Patients using MDI + CGM have greater reductions in HbA1c than those using CSII + CGM.
- Reductions in glycemic variability and time spent in hypoglycemia are not significantly different between SAP and MDI/RT-CGM therapy groups.
- All of the above

Follow the link to see how you and your colleagues compare.

Which is not a side effect of SGLT-2 Inhibitors?

A. Kidney failure
B. Hyperkalemia
C. Ketoacidosis
D. Hypertension
E. Increased cholesterol levels
F. Serious urinary tract infections
G. Increased bladder cancer risk
H. Serious allergic reactions

Follow the link for the answer.

iFORA - Diabetes Manager app designed to make busy lives easier to manage. iFORA comes with advanced mobile technology, sleek interface design, detailed and yet careful data management tools to assist you in better diabetes management. The easy-to-use tools can help you better understand how your blood glucose level interlinks with a positive self-monitoring process through recording, tracking, seeing your diabetes information in statistic trend graphs, target pie charts and exporting data to Fora TeleHealth solution to share with your doctor.

Recommendations address screening, treatment approaches and emphasize shared decision making

Lixisenatide reduces progression of urinary albumin-creatinine ratio in patients with macroalbuminuria

Despite having been withdrawn, albiglutide is superior to placebo for reducing cardiovascular events

High HbA1c levels within two years of diagnosis predict increased risk for psychiatric diagnoses

Better glycemic control, reduced hypoglycemia risk for T1DM patients with suboptimal glycemic control

Sometimes we don’t share everything we know about a patient with them. We make that decision based on experience and how much data we think a particular patient can understand or use. This is definitely true when we consider using monitoring technology with patients. The use of CGM has definitely …